Healthy Adults
Conditions
Interventions
Intake of 4 capsules of test food A* daily for 12 weeks. *test food A and B are capsules containing either placebo 1000mg (4 capsules) or "
capsule in fluvic acid"
1000mg (4 capsules).
Intake of 4 capsules of test food B* daily for 12 weeks. *test food A and B are capsules containing either placebo 1000mg (4 capsules) or "
1000mg (4 capsules).
Sponsors
Akasaka Family Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Persons who received a sufficient explanation of the purpose and contents of the study, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2. Female who are 35 years old or more and under 65 years old
Exclusion criteria
Exclusion criteria: 1. Persons who have any disease and are judged to have necessary treatment by the principal investigator. 2. Persons who are taken or applied medications for the treatment in the last one month. (excluding medicine used for needed basis such as headache, menstrual cramps and colds, etc.) 3. Persons with medical history with visceral disease and blood disease. 4. Persons who are judged to have diseases by the principal investigator and result of blood test or self-report. 5. Persons with self-report of medical history within last 6 months. 6. Persons who have severe anemia. 7. Persons who have an addiction to alcohol or a mental disease. 8. Persons who are a smoker or has been smoking for within last 10 years. 9. Persons who may cause allergic symptoms to test foods. 10. Persons who received hormone replacement therapy in the past 6 months. 11. Persons who were hospitalized and received treatment in the past 6 months. 12. Persons whose life style will change during the study period. 13. Persons who plan to intake new health functional foods and supplement foods during the study period. 14. Persons who participates in other clinical studies or participated in the last 3 months or plan to participate in other clinical studies. 15. Persons who are pregnant, planning or hoping to be pregnant during the study period, currently lactating. 16. Persons who were judged as inappropriate for subjects by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -urinary 8-OHdG At the beginning of the test or after the intake for 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Blood test (IL-6, hsCRP) -Intestinal Flora(NGS) -Physical examination (body height, body weight, BMI, lean body mass) -Optical measurements of heavy metals , minerals test -AGE At the beginning of the test or after the intake for 12 weeks. | — |
Countries
Japan
Contacts
Public ContactEriko Watanabe
Healthcare Systems Co., Ltd. Research and Development Department
Outcome results
None listed